logo-loader
viewJames Fisher & Sons PLC

James Fisher and Sons names new CEO ahead of October handover

Eoghan O'Lionaird joins the company in September before becoming chief executive in October.

offshore worker
Outgoing boss Nick Henry will remain with the company until March

James Fisher and Sons Plc (LON:FSJ) has announced the intended appointment of Eoghan O'Lionaird as a director in September, and on 1 October he will become the marine services company’s chief executive.

It is part of a succession plan which also sees Nick Henry, who has been chief executive for fifteen years, remain with the company until March to ‘ensure a smooth and effective transition of responsibility.’

READ: James Fisher steers towards positive outlook

O'Lionaird joins from Spectris PLC where he has been a divisional chief executive and part of the group’s executive committee.

“Eoghan has gained significant business experience in growing decentralised businesses both through organic and acquisitive strategies,” said Malcolm Paul, James Fisher chairman.

“A strong motivational and results driven leader, Eoghan has a history of creating highly engaged teams, which suits the James Fisher culture, and with excellent international business experience he has the drive to help take the group to the next level.

“I am very pleased that we have been able to attract someone with his track record and I look forward to working with Eoghan and the executive team to continue to deliver the excellent growth potential inherent within our business."

Quick facts: James Fisher & Sons PLC

Price: 2020 GBX

LSE:FSJ
Market: LSE
Market Cap: £1.02 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

2 days, 1 hour ago

2 min read